arrow
A

Aaron R. Thorner

center for cancer genomics
H指数:50
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma

融合驱动致癌程序塑造重排型肾细胞癌的免疫景观

2026-08-260
OA
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss

单细胞表观遗传图谱揭示了一种与不良预后和BAP1缺失相关的ccRCC肿瘤内干扰素应答程序。

2026-02-200
OA
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity
2026-01-210
PRE
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

早期激素受体阳性乳腺癌在抗PD-1和化疗治疗期间细胞的重编程

2025-11-280
OAAI
Understanding tumor-immune-stromal dynamics driving response and resistance to immune checkpoint blockade in melanoma
2025-11-010
PRE
fusion derived oncogenic programs shape the immune landscape in translocation renal cell carcinoma

融合衍生致癌程序塑造易位性肾细胞癌的免疫景观

2025-10-010
OAAI
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features

跨临床病理特征的转移性乳腺癌活检的多模态单细胞和空间表达图

2024-10-301
OAAI
Dissecting tumor- immune interaction in response and resistance to immune checkpoint blockade in metastatic melanoma
2024-03-220
PRE
Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses
2022-03-3031
OAAI
Spatio-molecular dissection of the breast cancer metastatic microenvironment
2022-02-150
PRE
Genetic ancestry and lung cancer somatic mutations in patients of Latin American descent: Etiology and treatment implications
2022-01-010
PRE
RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics
2021-11-1519
OA